Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
TKNO | US
-0.19
-5.90%
Healthcare
Drug Manufacturers-Specialty & Generic
30/06/2024
23/04/2026
3.03
3.21
3.24
2.98
Alpha Teknova Inc. produces critical reagents for the research discovery development and commercialization of novel therapies vaccines and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation resuspension and purification. It serves life sciences market including pharmaceutical and biotechnology companies contract development and manufacturing organizations in vitro diagnostic franchises and academic and government research institutions. The company was founded in 1996 and is headquartered in Hollister California.
View LessLow Market Beta (-0.4 to 0.8)
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
91.3%1 month
84.4%3 months
90.5%6 months
77.2%-
-
4.23
0.39
0.27
-6.23
9.90
-
-23.44M
161.51M
161.51M
-
-53.05
-
-16.60
-41.51
2.05
1.32
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.69
Range1M
0.71
Range3M
1.63
Rel. volume
0.30
Price X volume
108.10K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Heron Therapeutics Inc | HRTX | Drug Manufacturers-Specialty & Generic | 0.9998 | 151.64M | -1.98% | n/a | -471.04% |
| Galectin Therapeutics Inc | GALT | Drug Manufacturers-Specialty & Generic | 2.37 | 147.60M | -3.27% | n/a | -113.78% |
| Canopy Growth Corporation | CGC | Drug Manufacturers-Specialty & Generic | 1.22 | 135.21M | -11.59% | n/a | 117.00% |
| CRDL | CRDL | Drug Manufacturers-Specialty & Generic | 1.36 | 108.28M | -9.93% | n/a | 1.07% |
| Universe Pharmaceuticals INC | UPC | Drug Manufacturers-Specialty & Generic | 3.36 | 79.45M | 1.82% | n/a | 24.34% |
| Cumberland Pharmaceuticals Inc | CPIX | Drug Manufacturers-Specialty & Generic | 3.9 | 54.97M | 27.87% | n/a | 81.86% |
| Cannex Capital Holdings Inc | ARRXF | Drug Manufacturers-Specialty & Generic | 0.21 | 53.52M | -4.98% | n/a | 0.50% |
| INC Research Holdings Inc | INCR | Drug Manufacturers-Specialty & Generic | 0.899 | 41.14M | 10.99% | n/a | 28.90% |
| SCYNEXIS Inc | SCYX | Drug Manufacturers-Specialty & Generic | 1.05 | 39.75M | 1.94% | n/a | 25.73% |
| Akanda Corp. Common Shares | AKAN | Drug Manufacturers-Specialty & Generic | 9.37 | 26.74M | -8.23% | n/a | -104.44% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 11 | 176.62M | 2.80% | n/a | 286.96% |
| Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 36.11 | 103.70M | -2.41% | 5.16 | 19.82% |
| Virco Mfg. Corporation | VIRC | Building Products & Equipment | 6.04 | 98.39M | 0.00% | 9.09 | 39.79% |
| ILAG | ILAG | Building Products & Equipment | 3.66 | 66.10M | -8.03% | n/a | 5.48% |
| Unifi Inc | UFI | Textile Manufacturing | 3.55 | 64.81M | -1.66% | n/a | 52.56% |
| Culp Inc | CULP | Textile Manufacturing | 3.04 | 37.97M | 1.00% | n/a | 11.29% |
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 0.5899 | 11.40M | 3.13% | n/a | 58.43% |
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.52 | 7.60M | -24.64% | 0.03 | 16.03% |
| The Dixie Group Inc | DXYN | Textile Manufacturing | 0.355 | 5.46M | -1.39% | n/a | 422.08% |
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.3768 | 3.52M | 0.65% | n/a | 17.32% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -6.23 | 24.85 | Cheaper |
| Ent. to Revenue | 9.90 | 361.91 | Cheaper |
| PE Ratio | - | 30.05 | - |
| Price to Book | 4.23 | 13.15 | Cheaper |
| Dividend Yield | - | 2.94 | - |
| Std. Deviation (3M) | 90.53 | 65.24 | Riskier |
| Debt to Equity | 0.39 | -1.88 | Expensive |
| Debt to Assets | 0.27 | 0.48 | Cheaper |
| Market Cap | 161.51M | 3.71B | Emerging |